TX HB2641

Prohibits health maintenance organizations and insurers from requiring preauthorization for specific health care services including emergency care, primary care, intervention-necessary care, outpatient mental health and substance use disorder treatment, cancer treatments following NCCN guidelines, and preventive services with "A" or "B" ratings from the U.S. Preventive Services Task Force

Eliminates preauthorization requirements for intravitreal drugs treating vision-threatening conditions like macular degeneration, pediatric hospice services, neonatal abstinence syndrome programs, and services provided under risk-sharing or capitation arrangements

Prevents insurers from denying or reducing payment for exempt services unless the physician knowingly misrepresented the service with intent to deceive or failed to substantially perform the service

Requires approved preauthorization for chronic health conditions to remain valid indefinitely unless the standard treatment for that condition changes

Applies to health benefit plans delivered, issued, or renewed on or after January 1, 2026, and excludes CHIP, children's health benefits plans under Chapter 63, and Medicaid programs from the new requirements